Literature DB >> 1111892

Urinary homovanillic acid, dopamine and norepinephrine excretion in patients with essential hypertension.

J L Cuche, O Kuchel, A Barbeau, J Genest.   

Abstract

Urinary excretion of dopamine, norepinephrine and homovanillic acid was measured in normotensive subjects and in patients with either labile of stable hypertension under conditions controlled for posture, sodium and potassium intake and time of day. Mean homovanillic acid excretion was 313.5 plus or minus 77.7 (SE) mug/4h in the normotensive patients. Mean values for the patients with labile or stable hypertension were significantly greater, at 2506 plus or minus 476 mug/4 h (P smaller than 0.001) and 795 plus or minus 170 mug/4 h (P smaller than 0.01), respectively. Urinary excretion of dopamine and norepinephrine tended to be elevated in patients with labile hypertension when compared with values in the control subjects and the patients with stable hypertension. The data are compatible with the hypothesis of adrenergic hyperactivity in labile hypertension and underline the biochemical heterogeneity of essential hypertension. Because the overlapping of values between control subjects and patients with labile hypertension was minimal, it is proposed that an elevated valve for urinary homovanillic acid could be used as a biochemical marker to identify the patients with labile hypertension.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1111892      PMCID: PMC1956177     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  8 in total

1.  Determination of catecholamines and catecholamino acids by differential spectrophotofluorimetry.

Authors:  T L SOURKES; G F MURPHY
Journal:  Methods Med Res       Date:  1961

2.  An evaluation of four methods of measuring urinary creatinine.

Authors:  J M COOPER; H G BIGGS
Journal:  Clin Chem       Date:  1961-12       Impact factor: 8.327

3.  The metabolism of 3, 4-dihydroxyphenylalanine.

Authors:  K N SHAW; A MCMILLAN; M D ARMSTRONG
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

4.  Urinary excretion of dopamine and homovanillic acid in acute myocardial infarction.

Authors:  W Januszewicz; M Sznajderman; B Wocial; J Preibisz; W Poplawska
Journal:  Clin Chim Acta       Date:  1971-04       Impact factor: 3.786

Review 5.  The biosynthesis and metabolism of the catecholamines.

Authors:  M Sandler; C R Ruthven
Journal:  Prog Med Chem       Date:  1969

6.  The haemodynamic consequences of adaptive structural changes of the resistance vessels in hypertension.

Authors:  B Folkow
Journal:  Clin Sci       Date:  1971-07       Impact factor: 6.124

7.  Metabolism of 3-hydroxytyramine (dopamine) in human subjects.

Authors:  M Goodall; H Alton
Journal:  Biochem Pharmacol       Date:  1968-06       Impact factor: 5.858

8.  The quantitative determination of 3-methoxy-4-hydroxyphenylacetic acid (homovanillic acid) in urine.

Authors:  T L Sato
Journal:  J Lab Clin Med       Date:  1965-09
  8 in total
  1 in total

Review 1.  Role of the adrenal cortex and sodium in the pathogenesis of human hypertension.

Authors:  J Genest; W Nowaczynski; R Boucher; O Kuchel
Journal:  Can Med Assoc J       Date:  1978-03-04       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.